{"id":43682,"date":"2024-09-06T13:16:35","date_gmt":"2024-09-06T13:16:35","guid":{"rendered":"https:\/\/jornalboasnoticias.com.br\/home\/?p=43682"},"modified":"2024-09-06T13:16:35","modified_gmt":"2024-09-06T13:16:35","slug":"sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma","status":"publish","type":"post","link":"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/","title":{"rendered":"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma"},"content":{"rendered":"
\n
\"\"
\u00a9 Marcello Casal Jr.\/Ag\u00eancia Brasil<\/figcaption><\/figure>\n
\n

Conitec aprova betadinutuximabe, conhecido como Qarziba<\/p>\n<\/blockquote>\n<\/div>\n

A Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade (Conitec) recomendou nesta quinta-feira (5) a incorpora\u00e7\u00e3o do medicamento betadinutuximabe ao tratamento do neuroblastoma de alto risco. Isso significa que o rem\u00e9dio passar\u00e1 a ser custeado e distribu\u00eddo pelo Sistema \u00danico de Sa\u00fade (SUS). A condi\u00e7\u00e3o para o tratamento \u00e9 a de que o paciente tenha sido previamente tratado com quimioterapia e alcan\u00e7ado pelo menos uma resposta parcial, seguida de terap\u00eautica mieloablativa e transplante de c\u00e9lulas tronco.<\/p>\n

O pedido de incorpora\u00e7\u00e3o do medicamento foi submetido \u00e0 Conitec em janeiro deste ano pelo laborat\u00f3rio farmac\u00eautico Recordati, que comercializa o rem\u00e9dio com o nome Qarziba.<\/p>\n

O neuroblastoma \u00e9 o terceiro tipo de c\u00e2ncer infantil mais recorrente, depois da leucemia e de tumores cerebrais. O rem\u00e9dio, que custa cerca de R$ 2 milh\u00f5es, \u00e9 indicado para casos de alto risco ou recidiva e j\u00e1 foi utilizado em mais de mil pacientes de 18 pa\u00edses. Segundo o fabricante, ele melhora a sobrevida, aumenta a probabilidade de cura e reduz o risco de a doen\u00e7a voltar.<\/p>\n

Em janeiro deste ano, uma campanha de arrecada\u00e7\u00e3o de recursos para o tratamento de Pedro, filho do indigenista Bruno Pereira, chamou a aten\u00e7\u00e3o para a urg\u00eancia da incorpora\u00e7\u00e3o do betadinutuximabe ao SUS. Em apenas tr\u00eas dias, a campanha alcan\u00e7ou a meta, mas a fam\u00edlia de Pedro se uniu a\u00a0outras fam\u00edlias que tamb\u00e9m vivenciam a dificuldade\u00a0de acesso aos rem\u00e9dios para o tratamento do neuroblastoma.<\/p>\n

Na reuni\u00e3o da Conitec desta quinta-feira tamb\u00e9m foi aprovada a incorpora\u00e7\u00e3o ao SUS de novos rem\u00e9dios para doen\u00e7a pulmonar obstrutiva cr\u00f4nica. Confira as demais\u00a0delibera\u00e7\u00f5es da comiss\u00e3o aqui.<\/a><\/p>\n

 <\/p>\n

\n
\n
\"Neuroblastoma<\/div>\n<\/div>\n
\n
(Ag\u00eancia Brasil)<\/b><\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Conitec aprova betadinutuximabe, conhecido como Qarziba A Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema<\/p>\n","protected":false},"author":4,"featured_media":43683,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,7],"tags":[],"class_list":["post-43682","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destaques","category-saude"],"yoast_head":"\nSUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma - Jornal<\/title>\n<meta name=\"description\" content=\"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma - Jornal\" \/>\n<meta property=\"og:description\" content=\"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/\" \/>\n<meta property=\"og:site_name\" content=\"Jornal\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/boasnoticiasjornal\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-06T13:16:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2024\/09\/sus_vale_esta.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1170\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ana Luiza Bonatto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ana Luiza Bonatto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\\\/\"},\"author\":{\"name\":\"Ana Luiza Bonatto\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#\\\/schema\\\/person\\\/d641193e0afc6405b390164dac847971\"},\"headline\":\"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma\",\"datePublished\":\"2024-09-06T13:16:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\\\/\"},\"wordCount\":331,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/sus_vale_esta.jpg\",\"articleSection\":[\"DESTAQUE\",\"SA\u00daDE\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\\\/\",\"url\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\\\/\",\"name\":\"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma - Jornal\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/sus_vale_esta.jpg\",\"datePublished\":\"2024-09-06T13:16:35+00:00\",\"description\":\"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/sus_vale_esta.jpg\",\"contentUrl\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/sus_vale_esta.jpg\",\"width\":1170,\"height\":700,\"caption\":\"\u00a9 Marcello Casal Jr.\\\/Ag\u00eancia Brasil\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#website\",\"url\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/\",\"name\":\"Jornal Boas Not\u00edcias\",\"description\":\"Boas not\u00edcias\",\"publisher\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#organization\",\"name\":\"Coq Editora Ltda\",\"alternateName\":\"Jornal Boas Noticias\",\"url\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-logo.jpg\",\"width\":290,\"height\":142,\"caption\":\"Coq Editora Ltda\"},\"image\":{\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/boasnoticiasjornal\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/#\\\/schema\\\/person\\\/d641193e0afc6405b390164dac847971\",\"name\":\"Ana Luiza Bonatto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8a055ebe6373371f67ac6fcf313c0ac0b0a91157fdcdb9514fa62927373348f0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8a055ebe6373371f67ac6fcf313c0ac0b0a91157fdcdb9514fa62927373348f0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8a055ebe6373371f67ac6fcf313c0ac0b0a91157fdcdb9514fa62927373348f0?s=96&d=mm&r=g\",\"caption\":\"Ana Luiza Bonatto\"},\"url\":\"https:\\\/\\\/jornalboasnoticias.com.br\\\/home\\\/author\\\/ana-luiza\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma - Jornal","description":"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/","og_locale":"pt_BR","og_type":"article","og_title":"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma - Jornal","og_description":"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma","og_url":"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/","og_site_name":"Jornal","article_publisher":"https:\/\/www.facebook.com\/boasnoticiasjornal","article_published_time":"2024-09-06T13:16:35+00:00","og_image":[{"width":1170,"height":700,"url":"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2024\/09\/sus_vale_esta.jpg","type":"image\/jpeg"}],"author":"Ana Luiza Bonatto","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Ana Luiza Bonatto","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/#article","isPartOf":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/"},"author":{"name":"Ana Luiza Bonatto","@id":"https:\/\/jornalboasnoticias.com.br\/home\/#\/schema\/person\/d641193e0afc6405b390164dac847971"},"headline":"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma","datePublished":"2024-09-06T13:16:35+00:00","mainEntityOfPage":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/"},"wordCount":331,"commentCount":0,"publisher":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/#organization"},"image":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/#primaryimage"},"thumbnailUrl":"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2024\/09\/sus_vale_esta.jpg","articleSection":["DESTAQUE","SA\u00daDE"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/","url":"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/","name":"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma - Jornal","isPartOf":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/#primaryimage"},"image":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/#primaryimage"},"thumbnailUrl":"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2024\/09\/sus_vale_esta.jpg","datePublished":"2024-09-06T13:16:35+00:00","description":"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma","breadcrumb":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/#primaryimage","url":"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2024\/09\/sus_vale_esta.jpg","contentUrl":"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2024\/09\/sus_vale_esta.jpg","width":1170,"height":700,"caption":"\u00a9 Marcello Casal Jr.\/Ag\u00eancia Brasil"},{"@type":"BreadcrumbList","@id":"https:\/\/jornalboasnoticias.com.br\/home\/sus-passara-a-custear-novo-remedio-para-tratamento-de-neuroblastoma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/jornalboasnoticias.com.br\/home\/"},{"@type":"ListItem","position":2,"name":"SUS passar\u00e1 a custear novo rem\u00e9dio para tratamento de neuroblastoma"}]},{"@type":"WebSite","@id":"https:\/\/jornalboasnoticias.com.br\/home\/#website","url":"https:\/\/jornalboasnoticias.com.br\/home\/","name":"Jornal Boas Not\u00edcias","description":"Boas not\u00edcias","publisher":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jornalboasnoticias.com.br\/home\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/jornalboasnoticias.com.br\/home\/#organization","name":"Coq Editora Ltda","alternateName":"Jornal Boas Noticias","url":"https:\/\/jornalboasnoticias.com.br\/home\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/jornalboasnoticias.com.br\/home\/#\/schema\/logo\/image\/","url":"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2024\/07\/cropped-logo.jpg","contentUrl":"https:\/\/jornalboasnoticias.com.br\/home\/wp-content\/uploads\/2024\/07\/cropped-logo.jpg","width":290,"height":142,"caption":"Coq Editora Ltda"},"image":{"@id":"https:\/\/jornalboasnoticias.com.br\/home\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/boasnoticiasjornal"]},{"@type":"Person","@id":"https:\/\/jornalboasnoticias.com.br\/home\/#\/schema\/person\/d641193e0afc6405b390164dac847971","name":"Ana Luiza Bonatto","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/8a055ebe6373371f67ac6fcf313c0ac0b0a91157fdcdb9514fa62927373348f0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8a055ebe6373371f67ac6fcf313c0ac0b0a91157fdcdb9514fa62927373348f0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8a055ebe6373371f67ac6fcf313c0ac0b0a91157fdcdb9514fa62927373348f0?s=96&d=mm&r=g","caption":"Ana Luiza Bonatto"},"url":"https:\/\/jornalboasnoticias.com.br\/home\/author\/ana-luiza\/"}]}},"_links":{"self":[{"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/posts\/43682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/comments?post=43682"}],"version-history":[{"count":1,"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/posts\/43682\/revisions"}],"predecessor-version":[{"id":43684,"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/posts\/43682\/revisions\/43684"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/media\/43683"}],"wp:attachment":[{"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/media?parent=43682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/categories?post=43682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jornalboasnoticias.com.br\/home\/wp-json\/wp\/v2\/tags?post=43682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}